A clinical trial to study the prediction of result of chemotherapy in Acute myeloid leukemia by evaluating in vitro DNA damage.
Not Applicable
- Registration Number
- CTRI/2010/091/000015
- Lead Sponsor
- Dr. KH Reeta,Assistant professorDepartment of PharmacologyAIIMS, New Delhi-110029
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Patients of acute myeloid leukemia of either sex in the age ≤ 60 years who are willing for treatment.
Exclusion Criteria
(1) Patients with aleukemic leukemia.
(2) Patients with AML M3 sub type.
(3) Patients with contraindication for chemotherapy.
(4) Patients not willing for the treatment.
(5) Patients not giving written consent for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation between the results of in vitro study and outcome of induction chemotherapy in terms of complete remission achieved or not.Timepoint: Baseline and at 21-28 days after induction chemotherapy
- Secondary Outcome Measures
Name Time Method To see if there is any difference in the study results from bone marrow samples and peripheral blood samples.Timepoint: 21-28 days after induction chemotherapy